$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

$nhc Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000143774920009844 Filed on May 07, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$256.1M	$248.3M
YoY Change	3.16%	2.19%
Cost Of Revenue	$146.6M	$141.4M
YoY Change	3.72%	0.92%
Gross Profit	$109.5M	$106.9M
YoY Change	2.42%	3.88%
Gross Profit Margin	42.75%	43.05%
Selling, General & Admin	$10.33M	$10.24M
YoY Change	0.92%	0.37%
% of Gross Profit	9.44%	9.58%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.44M	$10.52M
YoY Change	-0.75%	1.69%
% of Gross Profit	9.53%	9.84%
Operating Expenses	$91.49M	$90.19M
YoY Change	1.44%	5.11%
Operating Profit	$15.81M	$15.78M
YoY Change	0.13%	-0.62%
Interest Expense	$412.0K	$926.0K
YoY Change	-55.51%	-25.32%
% of Operating Profit	2.61%	5.87%
Other Income/Expense, Net	$8.146M	$6.001M
YoY Change	35.74%	-295.79%
Pretax Income	-$36.44M	$28.62M
YoY Change	-227.31%	-1160.5%
Income Tax	-$9.625M	$7.392M
% Of Pretax Income		25.83%
Net Earnings	-$26.85M	$21.27M
YoY Change	-226.25%	-862.06%
Net Earnings / Revenue	-10.48%	8.57%
Basic Earnings Per Share	-$1.76	$1.39
Diluted Earnings Per Share	-$1.76	$1.39
COMMON SHARES
Basic Shares Outstanding	15.29M	15.26M
Diluted Shares Outstanding	15.29M	15.32M

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$86.18M	$51.68M
YoY Change	66.75%	-29.23%
Cash & Equivalents	$69.49M	$38.19M
Short-Term Investments	$16.69M	$13.49M
Other Short-Term Assets	$35.03M	$32.87M
YoY Change	6.57%	4.68%
Inventory	$7.904M	$6.953M
Prepaid Expenses
Receivables	$100.4M	$100.6M
Other Receivables	$1.785M	$1.417M
Total Short-Term Assets	$306.7M	$327.1M
YoY Change	-6.25%	7.19%
LONG-TERM ASSETS
Property, Plant & Equipment	$540.6M	$532.8M
YoY Change	1.47%	-2.43%
Goodwill	$21.34M	$21.00M
YoY Change	1.65%	19.29%
Intangibles
YoY Change
Long-Term Investments	$38.77M	$34.78M
YoY Change	11.49%	26.46%
Other Assets	$409.0M	$452.4M
YoY Change	-9.59%	117.51%
Total Long-Term Assets	$949.6M	$985.2M
YoY Change	-3.61%	30.65%
TOTAL ASSETS
Total Short-Term Assets	$306.7M	$327.1M
Total Long-Term Assets	$949.6M	$985.2M
Total Assets	$1.256B	$1.312B
YoY Change	-4.27%	23.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$18.28M	$19.32M
YoY Change	-5.4%	15.68%
Accrued Expenses	$103.1M	$97.51M
YoY Change	5.71%	34.69%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$50.00M
YoY Change
Total Short-Term Liabilities	$218.0M	$170.0M
YoY Change	28.25%	29.1%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$55.00M
YoY Change	-100.0%	-45.0%
Other Long-Term Liabilities	$14.59M	$15.31M
YoY Change	-4.68%	-5.12%
Total Long-Term Liabilities	$14.59M	$70.31M
YoY Change	-79.25%	-39.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$218.0M	$170.0M
Total Long-Term Liabilities	$14.59M	$70.31M
Total Liabilities	$513.0M	$561.6M
YoY Change	-8.66%	52.78%
SHAREHOLDERS EQUITY
Retained Earnings	$518.3M	$530.1M
YoY Change	-2.22%	11.0%
Common Stock	$153.0K	$153.0K
YoY Change	0.0%	0.66%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$742.6M	$749.6M
YoY Change
Total Liabilities & Shareholders Equity	$1.256B	$1.312B
YoY Change	-4.27%	23.89%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	-$26.85M	$21.27M
YoY Change	-226.25%	-862.06%
Depreciation, Depletion And Amortization	$10.44M	$10.52M
YoY Change	-0.75%	1.69%
Cash From Operating Activities	$7.754M	$11.60M
YoY Change	-33.16%	-12.81%
INVESTING ACTIVITIES
Capital Expenditures	$6.628M	$5.874M
YoY Change	12.84%	-17.27%
Acquisitions
YoY Change
Other Investing Activities	-$9.597M	$2.927M
YoY Change	-427.88%	125.15%
Cash From Investing Activities	-$16.23M	-$2.947M
YoY Change	450.56%	-49.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	-$347.0K	$293.0K
YoY Change	-218.43%	-246.5%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$31.64M	-$8.875M
YoY Change	-456.52%	8.78%
NET CHANGE
Cash From Operating Activities	$7.754M	$11.60M
Cash From Investing Activities	-$16.23M	-$2.947M
Cash From Financing Activities	$31.64M	-$8.875M
Net Change In Cash	$23.17M	-$221.0K
YoY Change	-10584.16%	-67.55%
FREE CASH FLOW
Cash From Operating Activities	$7.754M	$11.60M
Capital Expenditures	$6.628M	$5.874M
Free Cash Flow	$1.126M	$5.727M
YoY Change	-80.34%	-7.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	15357674
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	45000000
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15346601
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15346601
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	15332206
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15332206
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.52
CY2020Q1	nhc	Number Of Independent Living Facilities NumberOfIndependentLivingFacilities	5	pure
CY2020Q1	nhc	Number Of Geriatric Psychiatric Hospitals NumberOfGeriatricPsychiatricHospitals	1	pure
CY2020Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	pure
CY2019Q4	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	7455000	USD
CY2019Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2035000	USD
CY2019Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2020Q1	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0	USD
CY2019Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	244095000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	236111000	USD
CY2020Q1	nhc	Other Revenues OtherRevenues	12029000	USD
CY2019Q1	nhc	Other Revenues OtherRevenues	12174000	USD
CY2020Q1	us-gaap	Revenues Revenues	256124000	USD
CY2019Q1	us-gaap	Revenues Revenues	248285000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	147469000	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	141388000	USD
CY2020Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	71668000	USD
CY2019Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	69432000	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10332000	USD
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10238000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10438000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10517000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	412000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	926000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	240319000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	232501000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15805000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15784000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8146000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6001000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	6838000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-36441000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	28623000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9625000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7392000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-26816000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	21231000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	36000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-38000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-26852000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21269000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.76
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.76
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.39
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15294777
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15256189
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15294777
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15324125
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.52
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.50
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-26816000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	21231000	USD
CY2020Q1	nhc	Other Comprehensive Income Loss Securities Restricted Marketable Debt Securities Unrealized Holding Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossSecuritiesRestrictedMarketableDebtSecuritiesUnrealizedHoldingGainLossArisingDuringPeriodBeforeTax	-2545000	USD
CY2019Q1	nhc	Other Comprehensive Income Loss Securities Restricted Marketable Debt Securities Unrealized Holding Gain Loss Arising During Period Before Tax OtherComprehensiveIncomeLossSecuritiesRestrictedMarketableDebtSecuritiesUnrealizedHoldingGainLossArisingDuringPeriodBeforeTax	3225000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	2000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Before Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax	-0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-535000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	677000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2012000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2548000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	36000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-38000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-28864000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	23817000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69492000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	50334000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	12947000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	8944000	USD
CY2020Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	92061000	USD
CY2019Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	152453000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	16685000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	20576000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	100411000	USD
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	92975000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	7904000	USD
CY2019Q4	us-gaap	Inventory Net InventoryNet	7441000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5397000	USD
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4075000	USD
CY2020Q1	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1785000	USD
CY2019Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	1695000	USD
CY2020Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2019Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	2560000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	306682000	USD
CY2019Q4	us-gaap	Assets Current AssetsCurrent	341053000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1032795000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1017204000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	492175000	USD
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	481774000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	540620000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	535430000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	126830000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1741000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	1732000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities Noncurrent AvailableForSaleSecuritiesDebtSecuritiesNoncurrent	131126000	USD
CY2020Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5897000	USD
CY2019Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	5124000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	196960000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	202909000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	21341000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	20995000	USD
CY2020Q1	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	13168000	USD
CY2019Q4	us-gaap	Notes And Loans Receivable Net Noncurrent NotesAndLoansReceivableNetNoncurrent	13384000	USD
CY2020Q1	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	38772000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	39191000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	409005000	USD
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	410165000	USD
CY2020Q1	us-gaap	Assets Assets	1256307000	USD
CY2019Q4	us-gaap	Assets Assets	1286648000	USD
CY2020Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	18275000	USD
CY2019Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	18903000	USD
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4228000	USD
CY2019Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4166000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24557000	USD
CY2019Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24243000	USD
CY2020Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	48892000	USD
CY2019Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	69826000	USD
CY2020Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	15607000	USD
CY2019Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	15108000	USD
CY2020Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	29632000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	29520000	USD
CY2020Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	18811000	USD
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15029000	USD
CY2020Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	7980000	USD
CY2019Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	7968000	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	50000000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10000000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	217982000	USD
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	194763000	USD
CY2020Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13882000	USD
CY2019Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	14963000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	172403000	USD
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	178666000	USD
CY2020Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	71130000	USD
CY2019Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	66491000	USD
CY2020Q1	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	7455000	USD
CY2019Q4	us-gaap	Contract With Customer Refund Liability Noncurrent ContractWithCustomerRefundLiabilityNoncurrent	7455000	USD
CY2020Q1	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2035000	USD
CY2019Q4	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2035000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	8469000	USD
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	24012000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14590000	USD
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16058000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	5006000	USD
CY2019Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	3136000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	512952000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	507579000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	153000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	153000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	223600000	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	222787000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	518261000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	553093000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	548000	USD
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2560000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	742562000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	778593000	USD
CY2020Q1	us-gaap	Minority Interest MinorityInterest	793000	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	476000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	743355000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	779069000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1256307000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1286648000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-26816000	USD
CY2019Q1	us-gaap	Profit Loss ProfitLoss	21231000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10438000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10517000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2811000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2321000	USD
CY2020Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	2349000	USD
CY2019Q1	us-gaap	Equity Method Investment Dividends Or Distributions EquityMethodInvestmentDividendsOrDistributions	31000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	6838000	USD
CY2020Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	2000	USD
CY2019Q1	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	-0	USD
CY2020Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	1707000	USD
CY2019Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	-0	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	15008000	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1603000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	466000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	424000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	6212000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3345000	USD
CY2020Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-2560000	USD
CY2019Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-0	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	372000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-517000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1515000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1008000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1408000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-441000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-21343000	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-21730000	USD
CY2020Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	353000	USD
CY2019Q1	nhc	Increase Decrease In Due To Third Party Payors IncreaseDecreaseInDueToThirdPartyPayors	185000	USD
CY2020Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4623000	USD
CY2019Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	2498000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	3365000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	8158000	USD
CY2020Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-1468000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	102000	USD
CY2020Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1870000	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	2018000	USD
CY2020Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	6360000	USD
CY2019Q1	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	3565000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	3410000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	6576000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16225000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2947000	USD
CY2020Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	40000000	USD
CY2019Q1	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2019Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	31641000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7754000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11601000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6628000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5874000	USD
CY2020Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	6648000	USD
CY2019Q1	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	-0	USD
CY2020Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	250000	USD
CY2019Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	312000	USD
CY2020Q1	nhc	Payments For Proceeds From Unconsolidated Investments PaymentsForProceedsFromUnconsolidatedInvestments	125000	USD
CY2019Q1	nhc	Payments For Proceeds From Unconsolidated Investments PaymentsForProceedsFromUnconsolidatedInvestments	125000	USD
CY2020Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	376000	USD
CY2019Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	353000	USD
CY2020Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	1019000	USD
CY2019Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	959000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7968000	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	7623000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	400000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	579000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	53000	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	872000	USD
CY2020Q1	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	281000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-8875000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	23170000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-221000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	61010000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54920000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84180000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54699000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69492000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38194000	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	14688000	USD
CY2019Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16505000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84180000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	54699000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	734457000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21269000	USD
CY2019Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-38000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	2548000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	424000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	579000	USD
CY2019Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	872000	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7652000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	750715000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	779069000	USD
CY2020Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	36000	USD
CY2020Q1	nhc	Noncontrolling Interest Increase From Capital Contribution NoncontrollingInterestIncreaseFromCapitalContribution	281000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2012000	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-26852000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	466000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	400000	USD
CY2020Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	53000	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	7980000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	743355000	USD
CY2020Q1	nhc	Number Of Skilled Nursing Centers NumberOfSkilledNursingCenters	75	pure
CY2020Q1	nhc	Number Of Beds NumberOfBeds	9513	pure
CY2020Q1	nhc	Number Of Assisted Living Facilities NumberOfAssistedLivingFacilities	25	pure
CY2020Q1	nhc	Number Of Homecare Programs NumberOfHomecarePrograms	35	pure
CY2020Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	10	pure
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Estimates and Assumptions</i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period, including but <em style="font: inherit;">not</em> limited to, the potential future effects of the novel coronavirus (“COVID-<em style="font: inherit;">19”</em>).</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i> </i></p>
CY2019Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1047000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4929000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	4451000	USD
CY2020Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	830000	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3059000	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1813000	USD
CY2020Q1	us-gaap	Contract With Customer Refund Liability ContractWithCustomerRefundLiability	7455000	USD
CY2020Q1	us-gaap	Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount	2035000	USD
CY2020Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i>Prior Period Classifications</i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><i> </i></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;text-indent:36pt;">Certain amounts in prior periods have been reclassified to conform with current period presentation.</p>
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	244095000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	236111000	USD
CY2020Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1	pure
CY2019Q1	nhc	Revenue From Contract With Customer Including Assessed Tax Percentage RevenueFromContractWithCustomerIncludingAssessedTaxPercentage	1	pure
CY2020Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5679000	USD
CY2019Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	5608000	USD
CY2020Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	4478000	USD
CY2019Q1	nhc	Management And Accounting Services Fees Revenue ManagementAndAccountingServicesFeesRevenue	4751000	USD
CY2020Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1382000	USD
CY2019Q1	us-gaap	Insurance Services Revenue InsuranceServicesRevenue	1524000	USD
CY2020Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	490000	USD
CY2019Q1	nhc	Miscellaneous Revenue MiscellaneousRevenue	291000	USD
CY2020Q1	nhc	Other Revenues OtherRevenues	12029000	USD
CY2019Q1	nhc	Other Revenues OtherRevenues	12174000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	5503000	USD
CY2019Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	5477000	USD
CY2020Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	176000	USD
CY2019Q1	us-gaap	Operating Lease Variable Lease Income OperatingLeaseVariableLeaseIncome	131000	USD
CY2020Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5679000	USD
CY2019Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	5608000	USD
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2811000	USD
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	2321000	USD
CY2020Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	2022000	USD
CY2019Q1	nhc	Dividends And Other Net Realized Gains And Losses On Sales Of Securities DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities	1931000	USD
CY2020Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1606000	USD
CY2019Q1	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	1749000	USD
CY2020Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	1707000	USD
CY2019Q1	nhc	Gain Loss On Acquisition Of Equity Method Investment GainLossOnAcquisitionOfEquityMethodInvestment	0	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8146000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6001000	USD
CY2020Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	pure
CY2020Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	244095000	USD
CY2020Q1	nhc	Other Revenues OtherRevenues	12029000	USD
CY2020Q1	us-gaap	Revenues Revenues	256124000	USD
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	147469000	USD
CY2020Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	71668000	USD
CY2020Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10332000	USD
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10438000	USD
CY2020Q1	us-gaap	Interest Expense InterestExpense	412000	USD
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	240319000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15805000	USD
CY2020Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	8146000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-36441000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	236111000	USD
CY2019Q1	nhc	Other Revenues OtherRevenues	12174000	USD
CY2019Q1	us-gaap	Revenues Revenues	248285000	USD
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	141388000	USD
CY2019Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	69432000	USD
CY2019Q1	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	10238000	USD
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	10517000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	926000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	232501000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	15784000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6001000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	6838000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	28623000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	5200000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	35495000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	5200000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	35169000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	5200000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	34748000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	4766000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	34430000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	34279000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	65600000	USD
CY2020Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	20366000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	239721000	USD
CY2020Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2256000	USD
CY2020Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	42761000	USD
CY2020Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	18110000	USD
CY2020Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	4228000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	24557000	USD
CY2020Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	13882000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	172403000	USD
CY2020Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	196960000	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15294777
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15256189
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-26852000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21269000	USD
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.76
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15294777
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15256189
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	67936
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15294777
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15324125
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-26852000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	21269000	USD
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.76
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.39
CY2020Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	652208
CY2020Q1	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	177293000	USD
CY2020Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	239872000	USD
CY2019Q4	us-gaap	Available For Sale Securities Amortized Cost AvailableForSaleSecuritiesAmortizedCost	174342000	USD
CY2019Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	299859000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	14754000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	14600000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	15726000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	15767000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	94416000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	94603000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	88314000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	90408000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	37947000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	38608000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	40126000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	41231000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	0	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	0	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	0	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	147117000	USD
CY2020Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	147811000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	144166000	USD
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	147406000	USD
CY2020Q1	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	62244000	USD
CY2019Q4	nhc	Equity Securities Fv Ni Gross Unrealized Gain EquitySecuritiesFvNiGrossUnrealizedGain	122290000	USD
CY2020Q1	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	359000	USD
CY2019Q4	nhc	Equity Securities Fv Ni Gross Unrealized Loss EquitySecuritiesFvNiGrossUnrealizedLoss	13000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2019Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	6838000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3024000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3407000	USD
CY2020Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2330000	USD
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	167000	USD
CY2020Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	3410000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	6576000	USD
CY2020Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	2000	USD
CY2019Q1	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	USD
CY2020Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	USD
CY2020Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	50000000	USD
CY2019Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	10000000	USD
CY2020Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2019Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	USD
CY2020Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	466000	USD
CY2019Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	424000	USD
CY2020Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	4077000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0140	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0230	pure
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.166	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.174	pure
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P1Y10M24D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y3M18D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0255	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0273	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	53316
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1163381
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.16
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	77.89
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	346168
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	71.57
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	85000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	72.94
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	785529
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	71.24
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	57313
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	84.46
CY2020Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	7615
CY2020Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	65.37
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	835227
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	72.20
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1331000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	196414
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	68.31
CY2020Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	1001000	USD
CY2020Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	835227
CY2020Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	72.20
CY2020Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P2Y3D
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-9625000	USD
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.264	pure
CY2020Q1	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	205000	USD
CY2020Q1	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-60392000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7392000	USD
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.258	pure
CY2020Q1	nhc	Primary Insurance Coverage Amount Per Incident PrimaryInsuranceCoverageAmountPerIncident	1000000.0	USD
CY2020Q1	nhc	Primary Insurance Coverage Amount Per Location PrimaryInsuranceCoverageAmountPerLocation	3000000.0	USD
CY2019Q1	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	200000	USD
CY2019Q1	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-228000	USD
CY2020Q1	us-gaap	Self Insurance Reserve SelfInsuranceReserve	100762000	USD
CY2019Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	96011000	USD
CY2020Q1	nhc	Direct Business Coverage Statutory Limits DirectBusinessCoverageStatutoryLimits	1000000	USD
CY2020Q1	nhc	Annual Excess Coverage AnnualExcessCoverage	9000000.0	USD

Files In Submission

Name	View Source	Status
0001437749-20-009844-index-headers.html	Edgar Link	pending
0001437749-20-009844-index.html	Edgar Link	pending
0001437749-20-009844.txt	Edgar Link	pending
0001437749-20-009844-xbrl.zip	Edgar Link	pending
ex_183943.htm	Edgar Link	pending
ex_183944.htm	Edgar Link	pending
ex_183945.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nhc-20200331.xsd	Edgar Link	pending
nhc-20200331_cal.xml	Edgar Link	unprocessable
nhc-20200331_def.xml	Edgar Link	unprocessable
nhc-20200331_lab.xml	Edgar Link	unprocessable
nhc-20200331_pre.xml	Edgar Link	unprocessable
nhc20200331_10q.htm	Edgar Link	pending
nhc20200331_10qimg001.jpg	Edgar Link	pending
nhc20200331_10q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc

2020 Q1 Form 10-Q Financial Statement

#000143774920009844 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC NATIONAL HEALTHCARE CORP Stock $nhc

2020 Q1 Form 10-Q Financial Statement

#000143774920009844 Filed on May 07, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NHC
NATIONAL HEALTHCARE CORP Stock $nhc